NanoString Technologies

Employees:
410
Market Cap:
$402.93 million
Revenue:
$86.25 million
5 Year Trend:
37.1%
Net Income:
$-48.49 million
NASDAQ:
NSTG

NanoString Technologies, Inc. (NASDAQ: NSTG) is a publicly held biotech company that specializes in development of cancer diagnostics tools. The companys technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. Wikipedia

NanoString Technologies
Employees:
410
Market Cap:
$402.93 million
Revenue:
$86.25 million
5 Year Trend:
37.1%
Net Income:
$-48.49 million
NASDAQ:
NSTG

NanoString Technologies, Inc. (NASDAQ: NSTG) is a publicly held biotech company that specializes in development of cancer diagnostics tools. The companys technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. Wikipedia

Jun 5, 1:41 PM

"Molecular characterization of immune-related severe adverse events (irSAE)" at #ASCO17 presented by Justin Balko, PharmD, PhD of Vanderbilt University Medical Center!

Jun 4, 2:57 PM

See how we are driving cancer research forward at Booth 20097 during #ASCO17

May 15, 6:48 PM

Our #AAI2017 poster presentation is underway! Stop by, #839!

May 15, 4:25 PM

Have you stopped by our booth at #AAI2017 yet? Come check out our touch screen interactive wall and learn about our new products! Booth #218

12 jobs at NanoString Technologies

Jobs in